Eisai Plots A Meticulous Path To CMS Coverage For Lecanemab

US Exec Ivan Cheung Expects ‘More Open Access’ To Drug

Alzheimer's disease; brain and wooden puzzle on pink background
Eisai will piece together a detailed data package for CMS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapeutic Category